Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

A review on clotrimazole in the treatment of fungal infection

Breadcrumb

  • Home
  • A review on clotrimazole in the treatment of fungal infection

Bhumika Chandrakar 1, *, Naveen Kumar Sahu 2, Jyoti Prakash 2, Rukhmani Raman Sahu 2, Hariom Rajput 2 and Gyanesh Kumar Sahu 2

1 Rungta Institute of pharmaceutical Sciences and Research, Kohka, Kurud, Bhilai,490024, Chhattisgarh.
2 Rungta Institute of Pharmaceutical Sciences, Kohka, Kurud, Bhilai,490024, Chhattisgarh.
 

Review Article

World Journal of Biology Pharmacy and Health Sciences, 2025, 23(02), 223–231

Article DOI: 10.30574/wjbphs.2025.23.2.0753

DOI url: https://doi.org/10.30574/wjbphs.2025.23.2.0753

Received on 27 June 2025; revised on 11 August 2025; accepted on 13 August 2025

Mycoses, another name for fungal infections, are caused by pathogenic fungi that can infect many regions of the human body. These infections can be classified as superficial, cutaneous, subcutaneous, or systemic; systemic infections can result in serious and potentially fatal diseases. Human infections are frequently caused by fungi, including dermatophytes, Aspergillus, Candida, and Cryptococcus. Immunocompromised conditions (e.g., HIV/AIDS, organ transplantation, chemotherapy), diabetes, and long-term use of corticosteroids or broad-spectrum antibiotics are risk factors for fungal infections. Depending on the species of fungus and the infection site, the clinical symptoms can range from minor skin diseases to serious, widespread infections that impact internal organs such as the heart, brain, and lungs. Molecular methods, microbiological cultures, and clinical examination are commonly used in diagnosis. Among the available treatments are antifungal.

Fungal Infection; Clotrimazole; Allylamine; Mycoses

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2025-0753.pdf

Preview Article PDF

Bhumika Chandrakar, Naveen Kumar Sahu, Jyoti Prakash, Rukhmani Raman Sahu, Hariom Rajput and Gyanesh Kumar Sahu. A review on clotrimazole in the treatment of fungal infection. World Journal of Biology Pharmacy and Health Sciences, 2025, 23(02), 223-231. Article DOI: https://doi.org/10.30574/wjbphs.2025.23.2.0753.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution